Literature DB >> 30064916

Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations Between mRNA-Based Subtyping and CT Imaging Features.

Lan Bowen1, Li Xiaojing2.   

Abstract

PURPOSE: To investigate associations between clear-cell renal cell carcinoma mRNA-based subtyping and CT features.
MATERIALS AND METHODS: The CT data from 177 patients generated with The Cancer Imaging Archive were reviewed. The correlation was analyzed using chi-square test and univariate regression analysis.
RESULTS: Identified were 124 (53.2%) m1, 67 (28.8%) m2, 17 (7.3%) m3, and 14 (8.7%) m4 subtypes. m1-subtype rates were significantly higher in well-defined margin lesions (p = 0.041). m3-subtype rates were significantly higher in ill-defined margin lesions (p = 0.012), in collecting system invasion lesions (p = 0.028) and collecting system invasion lesions (p = 0.026).On univariate logistic regression analysis, tumor margin (well-defined margin vs ill-defined margin, OR: 2.104; p = 0.041; 95% CI: 1.024-4.322) was associated with m1-subtype. Tumor margin (well-defined margin vs ill-defined margin, OR: 2.104; p = 0.012; 95% CI: 0.212-0.834) and collecting system invasion (yes vs no, OR: 0.421; p = 0.028; 95% CI: 0.212-0.834) and renal vein invasion (yes vs no, OR: 2.164; p = 0.026; 95% CI: 1.090-4.294) were associated with m3-subtype. There was no significant difference between mRNA-based subtyping (m2 vs other; m4 vs other) and the CT features.
CONCLUSIONS: This preliminary radiogenomics analysis of clear-cell renal cell carcinoma revealed associations between CT features and mRNA-based subtyping which warrant further investigation and validation.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT features; Clear cell renal cell carcinoma; Logistic regression; Mrna-based subtyping; Radiogenomics

Mesh:

Substances:

Year:  2018        PMID: 30064916     DOI: 10.1016/j.acra.2018.05.002

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features.

Authors:  Dongzhi Cen; Li Xu; Siwei Zhang; Zhiguang Chen; Yan Huang; Ziqi Li; Bo Liang
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

2.  Usefulness of computed tomography textural analysis in renal cell carcinoma nuclear grading.

Authors:  Israa Alnazer; Omar Falou; Pascal Bourdon; Thierry Urruty; Rémy Guillevin; Mohamad Khalil; Ahmad Shahin; Christine Fernandez-Maloigne
Journal:  J Med Imaging (Bellingham)       Date:  2022-09-13

Review 3.  Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions.

Authors:  Sari Khaleel; Andrew Katims; Shivaram Cumarasamy; Shoshana Rosenzweig; Kyrollis Attalla; A Ari Hakimi; Reza Mehrazin
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.575

Review 4.  The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics-Definition, Current Advances, and Future Directions.

Authors:  Nikhil Gopal; Pouria Yazdian Anari; Evrim Turkbey; Elizabeth C Jones; Ashkan A Malayeri
Journal:  Cancers (Basel)       Date:  2022-02-04       Impact factor: 6.639

5.  TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review.

Authors:  Mario Zanfardino; Katia Pane; Peppino Mirabelli; Marco Salvatore; Monica Franzese
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

6.  Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.

Authors:  Yajuan Li; Xialing Huang; Yuwei Xia; Liling Long
Journal:  Abdom Radiol (NY)       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.